Just Released: Our 2018 Clinical Cancer Advances report
. names research by #MGH's , “Coping and prognostic awareness in patients with advanced cancer,” as one of the year’s top clinical cancer advances: . Congrats, Dr. Nipp!
Just in time for #WorldCancerDay tomorrow, read about the year's top advances in cancer research:
. names research by Dana-Farber’s as one of the year’s top clinical cancer advances:
The envelope, please: names #CAR-T Advance of the Year. 'Progress Against #Cancer ' report here: #WorldCancerDay
Gastric cancer research by Yale Cancer Center Director Dr. Charles Fuchs was named by as one of the year’s top clinical cancer advances:
. names Dr. 's “Alcohol and Cancer: A Statement of the American Society of Clinical Oncology” paper as one of 2018's top clinical cancer advances!
. names research by Dana-Farber’s Dr. Matthew B. Yurgelun as one of the year’s top clinical cancer advances:
Annual Report on Cancer Progress Report Highlights Life-Saving Potential of Immunotherapy, Critical Role of Federal Funding. #MultipleMyeloma #Immunotherapy #CarTCell
Research led by and William Shipley, MD, was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2018.
Precision Medicine and CAR T cell therapy among biggest advances in cancer care.
Not unexpected; #CART is the most impressive advance in cancer therapy in 2017 per
Clinical cancer advances and #CART tops the list.